Compare GLP-1 medicines in India
Head-to-head pages: how the medicines differ in what they’re approved for, how they’re taken, side effects, cost and coverage in India. Neutral and sourced, never a recommendation: your doctor decides which, if any, fits.
Comparisons
-
Bariatric surgery vs GLP-1 medicines: how do results, risks and costs compare in India?
Bariatric surgery gave 25% loss at 10 years in one study; GLP-1 injections 15–21% in trials. Risks, insurance rules and ₹ costs in India compared.
-
Mounjaro vs Ozempic: how do they differ in India?
Mounjaro (tirzepatide) acts on GIP and GLP-1; Ozempic (semaglutide) on GLP-1 only. India approvals, trial results with side effects, dose steps and MRPs.
-
Orlistat vs GLP-1 medicines: how do they compare?
Orlistat capsules block about 30% of fat absorption; GLP-1 medicines act on appetite. How orlistat is taken, trial results, side effects and prices in India.
-
Semaglutide vs tirzepatide dose chart: how do the doses compare?
Semaglutide and tirzepatide doses can't be swapped mg for mg. Every step for Ozempic, Wegovy, Rybelsus and Mounjaro in India, with MRPs per dose.
-
Wegovy vs Mounjaro: how do they compare in India?
Wegovy (semaglutide) acts on GLP-1; Mounjaro (tirzepatide) on GIP and GLP-1. Both are approved for weight in India. Head-to-head trial, harms, doses, MRPs.
-
Wegovy vs Ozempic: same medicine, different brand?
Wegovy and Ozempic are both semaglutide. In India, Ozempic is approved for type 2 diabetes and Wegovy for weight. Doses, pens, MRPs and label rules compared.
